Sunday, 9 November 2014
CMA pharma ban | Cancer survival lags | High rates of undiagnosed diabetes
The National Health and Family Planning Commission (NHFPC) is taking steps to curb hugely-profitable links between the Chinese Medical Association and the pharmaceutical and medical device industries. Although supposedly a non-profit organisation, the CMA makes 820 million yuan ($133 million) in income from industry-sponsored events such as medical conferences. The NHFPC has ordered the doctor's professional association to put its conference management on a more sound ethical footing and to stop promoting links between industry and the profession.
Cancer survival rates in China lag behind other countries
Cancer researchers have highlighted the huge disparity between cancer survival rates in China and in developed nations. A study of 139,000 Chinese cancer patients found that only about one-third of survived five years after their diagnosis, compared to 70% in counties such as the US. Researchers from the Cancer Prevention and Control Office said the poor survival rates in China ere due to poor levels of medical treatment and research. Another reason was that China had more cases of stomach, lung and liver cancers, which were more difficult to detect and treat than the common cancers in western countries.
High diabetes rates in central China
Diabetes has become a major public health problem in the region around the Three Gorges of the Yangtze, and a large number of the cases are undiagnosed and untreated. A study involving 3721 randomly selected adults found that the prevalence of diabetes and impaired fasting glucose were 7.6% and 9% respectively. About 55% of the cases of diabetes identified in the study were previously undiagnosed. The researchers from the Third Military Medical University, Chongqing said diabetes was linked to age, family history of diabetes, central obesity, educational level and hypertension for both men and women.